John Paolini

Chief Tech/Sci/R&D Officer at

Kiniksa Pharmaceuticals Ltd.

Net worth: 5 M $ as of 2026-07-30

61 year

43 connections

Health Technology

Consumer Services

Health Services

Profile

John F.
Paolini is Chief Medical Officer & Senior Vice President at Kiniksa Pharmaceuticals Ltd. since 2016.
Dr. Paolini is Chief Medical Officer & Executive Vice President at Kiniksa Pharmaceuticals International Plc since 2024.
Former roles include Senior Director-Cardiovascular Disease at Merck & Co., Inc., Head-Clinical Research-Cardiovascular at Pfizer Inc. from 2015 to 2016, Member at the University of Pennsylvania, Clinical Associate at Pennsylvania Hospital, Principal at Bayer HealthCare Pharmaceuticals, Inc., and Chief Medical Officer at Cerenis Therapeutics, Inc. from 2011 to 2015.
Education includes undergraduate studies at Tulane University (Louisiana) and graduate and doctorate degrees from Duke University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.14%	2026-04-30	65,623 ( 0.14% )	5 M $	2026-07-30

John Paolini active positions

Companies	Position	Start
Kiniksa Pharmaceuticals Ltd. Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases	Chief Tech/Sci/R&D Officer	2016-07-31

All active positions of John Paolini

Former positions of John Paolini

Companies	Position	End
PFIZER INC.	Corporate Officer/Principal	2016-07-31
Cerenis Therapeutics, Inc. Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs	Chief Tech/Sci/R&D Officer	2015-06-30
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Pennsylvania Hospital Pennsylvania Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services	Corporate Officer/Principal	-
Bayer HealthCare Pharmaceuticals, Inc. Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs	Corporate Officer/Principal	-

See the detail of John Paolini's experience

Training of John Paolini

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Paolini's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tulane University (Louisiana) Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pennsylvania Hospital Pennsylvania Hospital Hospital/Nursing ManagementHealth Services Provides healthcare services	Health Services
Bayer HealthCare Pharmaceuticals, Inc. Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs	Health Technology
Cerenis Therapeutics, Inc. Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs	Health Technology
Duke University School of Medicine Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kiniksa Pharmaceuticals Ltd. Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases	Health Technology